ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. - Ariceta G; Collard L; Abroug S; Moochhala SH; Gould E; Boussetta A; Ben Hmida M; De S; Hunley TE; Jarraya F; Fraga G; Banos A; et al. (Pediatric nephrology (Berlin, Germany), 2023)